WGRX Wellgistics: Total Company Value-to-Revenue Ratio

Public company logo of Wellgistics (WGRX)

Effective management within the strictly regulated pharma niche ensures supply chain transparency for Wellgistics Health Inc (WGRX). The enterprise value-to-sales multiple visualizes market expectations, where 2716.32 shows the current value of the metric. Robotic warehouses optimize medication distribution, reducing costs. Simultaneously, the company is implementing basic environmental standards to reduce fuel consumption during transport.

WGRX (Wellgistics Health, Inc.) EV/Sales Multiple history from 11/23/2025 to 07/22/2026

WGRX (Wellgistics Health, Inc.): analytical breakdowns and indicator data

- market price and analyst price targets:
Fundamental valuation:Wellgistics Health, Inc. WGRX
Manufactured product of Wellgistics Health

This indicator compares the total enterprise value, including debt and cash, against annual sales volume. By analyzing the enterprise value via EV/Sales, an investor determines the premium paid per unit of revenue regardless of the debt load. High values signal the risk of an overbought asset. For Wellgistics Health Inc (WGRX), this metric remains stable due to the resilience of pharmaceutical logistics. The non-cyclical demand for medications minimizes the metric's volatility during macroeconomic shocks.